LWA
BSX icon

Lineweaver Wealth Advisors’s Boston Scientific BSX Stock Holding History

Lineweaver Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,194
Closed -$640K – 184
2026
Q1 		$640K Buy
+10,194
New +$815K 0.09% 125
2025
Q4 		– Sell
-6,618
Closed -$646K – 183
2025
Q3 		$646K Buy
+6,618
New +$685K 0.09% 122

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lineweaver Wealth Advisors's BSX Position: Q2 2026 in Review

Lineweaver Wealth Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 10,194 shares — an estimated $640K sold.

Lineweaver Wealth Advisors first reported a position in BSX in Q3 2025 and held it in 2 quarters. The position peaked at $646K in Q3 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lineweaver Wealth Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Lineweaver Wealth Advisors sold 10,194 Boston Scientific shares in Q2 2026, an estimated $640K.
  • Lineweaver Wealth Advisors first reported a position in Boston Scientific in Q3 2025 and held it in 2 quarters.
  • Lineweaver Wealth Advisors's Boston Scientific position peaked at $646K in Q3 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lineweaver Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.